XML 77 R56.htm IDEA: XBRL DOCUMENT

Segment Information (Tables)

12 Months Ended

Dec. 31, 2021

The following tables present the special items recorded by the Company for the year ended December 31, 2021, 2020 and 2019:



(In millions)	2021	2020				2019
Description of Special Item Charges (Benefits) and Financial Statement Line Item(s)		After-tax		Before-tax		After-tax		Before-tax		After-tax		Before-tax
Charge for organizational efficiency plan (Selling, general and administrative expenses)		$	119	$	168	$	24	$	31	$	162	$	207
Debt extinguishment costs		110		141		151		199		—		—
Integration and transaction-related (benefits) costs (Selling, general and administrative expenses)		71		169		404		527		427		552
(Benefits) charges associated with litigation matters (Selling, general and administrative expenses)		(21)		(27)		19		25		41		51
Risk corridors recovery (Selling, general and administrative expenses)		—		—		(76)		(101)		—		—
Contractual adjustment for a former client (Pharmacy revenues)		—		—		(155)		(204)		—		—
(Gain) on sale of business		—		—		(3,217)		(4,203)		—		—

Total impact from special items		$	279	$	451	$	(2,850)	$	(3,726)	$	630	$	810

Summarized Segment Financial Information

Summarized segment financial information was as follows:


(In millions)	Evernorth		Cigna Healthcare		Other Operations		Corporate and Eliminations		Total
2021
Revenues from external customers	$	127,692	$	41,378	$	3,459	$	—	$	172,529
Inter-segment revenues	4,203		2,271		—		(6,474)
Net investment income	17		1,003		530		(1)		1,549
Total revenues	131,912		44,652		3,989		(6,475)		174,078
Net realized investment results from certain equity method investments	—		—		—		—		—

Adjusted revenues	$	131,912	$	44,652	$	3,989	$	(6,475)	$	174,078
Depreciation and amortization	$	2,316	$	551	$	52	$	4	$	2,923
Income (loss) before taxes	$	3,908	$	3,812	$	852	$	(1,790)	$	6,782
Pre-tax adjustments to reconcile to adjusted income from operations
(Income) attributable to noncontrolling interests	(31)		(3)		(24)		—		(58)
Net realized investment (gains) losses (1)	4		(247)		47		—		(196)
Amortization of acquired intangible assets	1,937		47		14		—		1,998
Special items
Charge for organizational efficiency plan	—		—		—		168		168
Debt extinguishment costs	—		—		—		141		141
Integration and transaction-related (benefits) costs	—		—		—		169		169
(Benefits) charges associated with litigation matters	—		—		—		(27)		(27)




Pre-tax adjusted income (loss) from operations	$	5,818	$	3,609	$	889	$	(1,339)	$	8,977

(In millions)	Evernorth		Cigna Healthcare		Other Operations		Corporate and Eliminations		Total
2020
Revenues from external customers	$	112,647	$	38,826	$	7,684	$	—	$	159,157
Inter-segment revenues	3,655		1,966		23		(5,644)
Net investment income	32		473		739		—		1,244
Total revenues	116,334		41,265		8,446		(5,644)		160,401

Net realized investment results from certain equity method investments	—		(130)		—		—		(130)
Special item related to contractual adjustment for a former client	(204)		—		—		—		(204)
Adjusted revenues	$	116,130	$	41,135	$	8,446	$	(5,644)	$	160,067
Depreciation and amortization	$	2,248	$	458	$	71	$	25	$	2,802
Income (loss) before taxes	$	3,684	$	4,291	$	5,227	$	(2,334)	$	10,868
Pre-tax adjustments to reconcile to adjusted income from operations
(Income) attributable to noncontrolling interests	(17)		(1)		(19)		—		(37)
Net realized investment (gains) losses (1)	(17)		(202)		(60)		—		(279)
Amortization of acquired intangible assets	1,917		44		21		—		1,982
Special items
Charge for organizational efficiency plan	—		—		—		31		31
Debt extinguishment costs	—		—		—		199		199
Integration and transaction-related (benefits) costs	—		—		—		527		527
(Benefits) charges associated with litigation matters	—		—		—		25		25
Risk corridors recovery	—		(101)		—		—		(101)
Contractual adjustment for a former client	(204)		—		—		—		(204)
(Gain) on sale of business	—		—		(4,203)		—		(4,203)

Pre-tax adjusted income (loss) from operations	$	5,363	$	4,031	$	966	$	(1,552)	$	8,808

(1) Includes the Company's share of certain realized investment results of its joint ventures reported in the Cigna Healthcare segment using the equity method of accounting.


(In millions)	Evernorth		Cigna Healthcare		Other Operations		Corporate and Eliminations		Total
2019
Revenues from external customers	$	107,354	$	37,455	$	7,367	$	—	$	152,176
Inter-segment revenues	2,380		1,168		26		(3,574)
Net investment income (loss)	60		510		822		(2)		1,390
Total revenues	109,794		39,133		8,215		(3,576)		153,566
Revenue contributions from transitioning clients	(13,347)		—		—		—		(13,347)
Net realized investment results from certain equity method investments	—		(44)		—		—		(44)

Adjusted revenues	$	96,447	$	39,089	$	8,215	$	(3,576)	$	140,175
Depreciation and amortization	$	3,071	$	492	$	85	$	3	$	3,651
Income (loss) before taxes	$	3,983	$	4,071	$	1,180	$	(2,664)	$	6,570
Pre-tax adjustments to reconcile to adjusted income from operations
Adjustment for transitioning clients	(1,726)		—		—		—		(1,726)
(Income) attributable to noncontrolling interests	(4)		—		(16)		—		(20)
Net realized investment (gains) losses (1)	—		(159)		(62)		—		(221)
Amortization of acquired intangible assets	2,839		81		29		—		2,949
Special items
Charge for organizational efficiency plan	—		—		—		207		207

Integration and transaction-related (benefits) costs	—		—		—		552		552
(Benefits) charges associated with litigation matters	—		(30)		—		81		51




Pre-tax adjusted income (loss) from operations	$	5,092	$	3,963	$	1,131	$	(1,824)	$	8,362

(1) Includes the Company's share of certain realized investment gains (losses) of its joint ventures reported in the Cigna Healthcare segment using the equity method of accounting.

Revenue from External Customers

Revenue from external customers includes Pharmacy revenues, Premiums and Fees and other revenues. The following table presents these revenues by product, premium and service type for the year ended December 31:



(In millions)	2021		2020		2019
Products (Pharmacy revenues) (ASC 606)
Network revenues	$	64,992	$	56,365	$	51,430
Home delivery and specialty revenues	54,391		49,906		49,226
Other	6,428		5,403		4,900
Intercompany eliminations	(4,398)		(3,905)		(2,457)
Total pharmacy revenues	121,413		107,769		103,099
Insurance premiums (ASC 944)
Cigna Healthcare
U.S. Commercial
Insured	14,315		13,389		12,523
Stop loss	4,868		4,614		4,328
Other	1,290		1,135		1,040
U.S. Government
Medicare Advantage	8,362		7,565		6,314
Medicare Part D	1,499		1,593		1,699
Other	4,815		4,301		4,185
International Health	2,588		2,472		2,382
Total Cigna Healthcare	37,737		35,069		32,471
International businesses held for sale	3,205		3,039		2,884
Domestic disability, life and accident	—		4,423		4,225
Other	221		124		147
Intercompany eliminations	(9)		(28)		(13)
Total premiums	41,154		42,627		39,714
Services (Fees) (ASC 606)

Evernorth	6,070		4,611		4,165
Cigna Healthcare	5,743		5,491		6,022
Other Operations	19		116		123
Other revenues	197		254		157
Intercompany eliminations	(2,067)		(1,711)		(1,104)
Total fees and other revenues	9,962		8,761		9,363
Total revenues from external customers	$	172,529	$	159,157	$	152,176

Foreign and U.S. Revenues from External Customers

Foreign and U.S. revenues from external customers for the three years ended December 31 are shown below. The Company's foreign revenues are generated by its foreign operating entities. In the periods shown, no foreign country contributed more than 2% of consolidated revenues from external customers.


(In millions)	2021		2020		2019
United States	$	166,626	$	154,042	$	147,332
Foreign countries (1)	5,903		5,115		4,844
Total	$	172,529	$	159,157	$	152,176

(1) International life, accident and supplemental benefits businesses in seven countries to be sold pursuant to the Chubb Transaction as described in Note 1 comprised of $3.2 billion, $3.1 billion and $2.9 billion in 2021, 2020 and 2019, respectively.